Literature DB >> 18166305

Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.

Inge P De Boer1, Eliane C M Zeestraten, Enrico Lopriore, Inge L van Kamp, Humphrey H H Kanhai, Frans J Walther.   

Abstract

OBJECTIVE: To study the short-term morbidity in Rhesus hemolytic disease of infants treated either with or without intrauterine transfusions (IUT). STUDY
DESIGN: All term and near term infants (gestational age > or = 36 weeks) with neonatal Rhesus hemolytic disease admitted to our center between January 2000-March 2005 were retrospectively included in the study. We recorded the duration of phototherapy, the need of exchange transfusions, and the need of top-up red blood cell transfusions until 6 months of age.
RESULTS: A total of 89 infants were included, of whom 52 received at least one IUT. Duration of phototherapy in the IUT and no-IUT group was 3.8 and 5.1 days, respectively (P = .01). The percentage of infants requiring an exchange transfusion in the IUT group was 71% compared to 65% in the no-IUT group (P = .64). The percentage of infants requiring a top-up transfusion in the IUT and no-IUT group was 77% and 26.5%, respectively (P < .01).
CONCLUSION: Infants with Rhesus hemolytic disease treated with IUT required less days of phototherapy and more top-up red blood cell transfusions than neonates without IUT. However, the need for exchange transfusion was similar in both groups.

Entities:  

Mesh:

Year:  2008        PMID: 18166305     DOI: 10.1016/j.ajog.2007.05.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Improving the management and outcome in haemolytic disease of the foetus and newborn.

Authors:  Enrico Lopriore; Mirjam E A Rath; Helen Liley; Vivianne E H J Smits-Wintjens
Journal:  Blood Transfus       Date:  2013-07-19       Impact factor: 3.443

2.  Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.

Authors:  Katherine A Birchenall; Sebastian E Illanes; Francisco Lopez; Timothy Overton; Rachel Liebling; Peter W Soothill; Sherif Abdel-Fattah; Mark Denbow
Journal:  Blood Transfus       Date:  2013-07-19       Impact factor: 3.443

3.  Neonatal outcome after fetal anemia managed by intrauterine transfusion.

Authors:  C Garabedian; T Rakza; D Thomas; B Wibaut; P Vaast; D Subtil; V Houfflin-Debarge
Journal:  Eur J Pediatr       Date:  2015-06-02       Impact factor: 3.183

4.  Obstetric management in Rh alloimmunizated pregnancy.

Authors:  Alessandra Cacciatore; Stefania Rapiti; Sabina Carrara; Alessandro Cavaliere; Santina Ermito; Angela Dinatale; Laura Imbruglia; Stefania Recupero; Tindara La Galia; Elisa Maria Pappalardo; Manuela Chiara Accardi
Journal:  J Prenat Med       Date:  2009-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.